Valli De Re Selected Research

Valli De Re Research Topics

Disease

29	Neoplasms (Cancer) 04/2024 - 04/2002
16	Stomach Neoplasms (Stomach Cancer) 11/2023 - 01/2013
13	Infections 01/2020 - 01/2005
11	Hodgkin Disease (Hodgkin's Disease) 12/2023 - 02/2005
8	Celiac Disease (Celiac Sprue) 01/2017 - 08/2007
6	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 02/2013
6	Lymphoma (Lymphomas) 01/2015 - 01/2002
5	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2012 - 01/2002
4	Atrophic Gastritis 05/2019 - 07/2016
4	Inflammation (Inflammations) 05/2019 - 11/2010
4	Cryoglobulinemia 01/2015 - 05/2003
3	Carcinoma (Carcinomatosis) 03/2018 - 05/2009
2	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2017
2	Adenocarcinoma 02/2022 - 04/2013
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 04/2013
2	Gastritis 01/2020 - 07/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 12/2007
2	Anemia 07/2014 - 03/2009
2	Persistent Infection 01/2014 - 01/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 01/2014
2	Hepatitis C 01/2014 - 05/2003
2	Viremia 10/2012 - 05/2003
2	Nasopharyngeal Carcinoma 09/2009 - 09/2008
1	Monoclonal Gammopathy of Undetermined Significance 04/2024
1	Multiple Myeloma 04/2024
1	Virus Diseases (Viral Diseases) 02/2022
1	Sclerosis 05/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 10/2019
1	Brain Neoplasms (Brain Tumor) 04/2019
1	Adenocarcinoma of Lung 04/2019
1	Microsatellite Instability 01/2018
1	Rectal Neoplasms (Rectal Cancer) 04/2017
1	Duodenal Ulcer (Curling's Ulcer) 01/2017
1	Thrombosis (Thrombus) 01/2017
1	Stomach Diseases 07/2016

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2007
7	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2018
6	Cadherins (E-Cadherin)IBA 07/2020 - 01/2013
4	Glutens (Glutelin)IBA 01/2017 - 12/2007
4	VaccinesIBA 10/2012 - 02/2010
3	Messenger RNA (mRNA)IBA 04/2024 - 01/2021
3	Pepsinogen A (Pepsinogen)IBA 02/2023 - 07/2016
3	gastrin 17 (G 17)IBA 02/2023 - 03/2018
3	Trastuzumab (Herceptin)FDA Link 02/2022 - 12/2017
3	AntigensIBA 01/2022 - 01/2005
3	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2018
3	LigandsIBA 10/2019 - 10/2011
3	Fibrinogen (Factor I)FDA Link 03/2018 - 01/2017
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2017 - 10/2011
3	Peptides (Polypeptides)IBA 04/2013 - 09/2008
3	AutoantibodiesIBA 11/2010 - 09/2007
3	RNA (Ribonucleic Acid)IBA 09/2008 - 05/2003
2	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2024 - 09/2015
2	Immunoglobulin G (IgG)IBA 02/2023 - 04/2002
2	Sorafenib (BAY 43-9006)FDA Link 02/2022 - 02/2013
2	Immune Checkpoint InhibitorsIBA 05/2021 - 10/2019
2	PepsinogensIBA 03/2018 - 07/2016
2	HLA-Bw4 antigenIBA 01/2015 - 01/2014
2	GliadinIBA 04/2013 - 05/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012 - 05/2006
2	AutoantigensIBA 12/2011 - 09/2007
2	EpitopesIBA 11/2010 - 09/2009
2	Interferon-alpha (Interferon Alfa)IBA 07/2010 - 05/2003
2	Ribavirin (Virazole)FDA LinkGeneric 07/2010 - 04/2009
2	Rituximab (Mabthera)FDA Link 07/2010 - 05/2003
2	InterferonsIBA 01/2010 - 04/2009
2	AntibodiesIBA 09/2009 - 04/2002
2	Rheumatoid FactorIBA 09/2009 - 04/2002
2	DNA (Deoxyribonucleic Acid)IBA 08/2008 - 04/2005
1	OsteopontinIBA 12/2023
1	human ERBB2 proteinIBA 02/2022
1	CateninsIBA 02/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	MucinsIBA 05/2021
1	Immune Checkpoint ProteinsIBA 05/2021
1	CTLA-4 AntigenIBA 05/2021
1	CytokinesIBA 05/2021
1	Janus KinasesIBA 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	FlagellinIBA 05/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2019
1	Pemetrexed (MTA)FDA Link 04/2019
1	Cisplatin (Platino)FDA LinkGeneric 04/2019
1	ErbB Receptors (EGF Receptor)IBA 04/2019
1	HLA-G Antigens (HLA G)IBA 12/2017
1	Thrombin FDA Link 01/2017
1	FibrinIBA 01/2017
1	Hemostatics (Antihemorrhagics)IBA 01/2017
1	Thromboplastin (Tissue Factor)IBA 01/2017
1	EnzymesIBA 07/2016
1	ImmunosorbentsIBA 07/2016

Therapy/Procedure

16	Therapeutics 07/2023 - 04/2002
4	Radiotherapy 01/2022 - 04/2017
2	Immunotherapy 05/2018 - 09/2008
2	Drug Therapy (Chemotherapy) 11/2017 - 01/2014
1	Cryosurgery 01/2022
1	Ligation 10/2019
1	Neoadjuvant Therapy 04/2017